Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Alembic Pharmaceuticals Limited has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 05-Aug-2025more...
Alembic Pharmaceuticals Limited has informed the Exchange regarding Submission of BRSR for the FY 2024-25 .more...
We enclose herewith the BRSR of the Company for the financial year ended 31st March 2025.more...
Pursuant to regulation 30 of SEBI LODR 2015 Please find enclosed herewith the 15th Notice of Annual General meeting of the Company scheduled...more...
We enclose herewith the notice of 15th Annual General Meeting of the Company scheduled to be held on 5th August 2025 at 3:00 PM through Video Confere...more...
Alembic Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 05 2025more...
Please find the Annual Report for the financial year ended 31st March 2025.more...
Alembic Pharmaceuticals Ltd. on Tuesday 06 May 2025 has announced Final dividend of 550 percent on Equity Share to its shareholders holding ...more...
Alembic Pharmaceuticals Limited has informed the Exchange about Credit Ratingmore...
Please find attached herewith the reaffirmation from Crisil Ratings Limited for Credit Rating on Commercial Papers with Enhanced Limitsmore...
Please find attached herewith the reaffirmation from CARE Ratings Limited of Credit Rating on Commercial Papers with Enhanced Limits.more...
Alembic Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 29-Jul-2025.more...
This is to inform that the Company has fixed the Record Date of 29th July 2025 for determining the entitlement of Members of the Company to ...more...
Alembic Pharmaceuticals Limited has informed the Exchange regarding USFDA inspection at Alembic Pharmaceuticals Limited s API - I & II Facility locat...more...
USFDA has conducted an inspection at our API-I & II facility loacted at Panelav.more...
Alembic Pharmaceuticals Limited announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated ...more...
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 30 2025 titled Alembic Pharmaceuticals receive...more...
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Bosutinib Tablets 100 mg and 500 mgmore...
Alembic Pharmaceuticals Limited has informed the Exchange about Update in the Schedule of meetmore...
Enter Stock
BOARD MEETINGS Company Name : Kuberan Global Edu Date : 24-06-2025